Canephron
Canephron is a medicine authorised by Swissmedic under authorisation number 67419. The authorisation holder is Biomed AG. The medicinal product code is Herbal medicines and the dispensing category is D: Supplied in pharmacies and drugstores after specialist advice, without a prescription. First authorisation was granted on 01 October 2020 and the authorisation is valid without a time limit. ATC code G04BX places the medicine in the group Urologicals.
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Canephron, überzogene Tabletten | D | 01 October 2020 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 30 | Dragée(s) | G04BX | 05.02.0. | D |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Canephron authorised in Switzerland?
Yes. Canephron is authorised by Swissmedic under authorisation number 67419, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Canephron have?
Canephron is in dispensing category D. Supplied in pharmacies and drugstores after specialist advice, without a prescription.
Who is the authorisation holder of Canephron?
The authorisation holder is Biomed AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.